BioMarin Pharmaceutical | BMRN - 市值

股票价格

53.18

每天变化

-0.80 -1.48%

每月一次

-4.34%

每年

-15.99%

Q2 预测

52.04

金融业

USD

USD 7.59B

现金及等价物

USD 1.31B

USD 161.56M

USD 3.95B

USD 759.03M

USD 604.24M

USD 198.39M

USD -24.17M

3.04K

EPS每股收益

USD 0.46

股本和储备

USD 6.09B

USD 713.01M

债务利息支出

USD 2.78M

USD 17.85M

USD 597.18M

USD 10.17B

USD -46.57M

USD 676.18M

USD 198.39M

普通股股本

USD 192.3M

19.24

USD -26.32M

USD 875M

销售和管理费用

USD 322.21M

USD 1.3B

贸易债权人

USD 759.03M

应收帐款人

USD 908.21M

	市值	更改		日
Acadia Pharmaceuticals	USD 4.52B		919M	2025-12
Agios Pharmaceuticals	USD 1.59B		745M	2025-12
Alnylam Pharmaceuticals	USD 52.54B		7.24B	2025-12
Amgen	USD 176.25B		24.32B	2025-12
Bayer	EUR 36.36B		9.13B	2025-12
Biogen	USD 25.82B		5.28B	2025-12
BioMarin Pharmaceutical	USD 11.42B		1.02B	2025-12
Gilead Sciences	USD 166.62B		14.34B	2026-04
Incyte	USD 19.39B		2.83B	2025-12
Insmed	USD 37.12B		6.68B	2025-12
Ionis Pharmaceuticals	USD 12.81B		2.39B	2025-12
Neurocrine Biosciences	USD 14.14B		218M	2025-12
PTC Therapeutics	USD 5.26B		844M	2026-04
Regeneron Pharmaceuticals	USD 81.12B		21.53B	2025-12
Roche Holding	CHF 266.34B		55.46B	2025-12
Sanofi	EUR 117.34B		2.45B	2025-12
Sarepta Therapeutics	USD 2.26B		238M	2025-12
Ultragenyx Pharmaceutical	USD 2.22B		680M	2025-12
United Therapeutics	USD 20.98B		2.02B	2025-12
Vertex Pharmaceuticals	USD 115.03B		14.61B	2025-12